[1] Claas Ulrich,Monika Hackethal,Thomas Meyer,et al.Skin infections in organ transplant recipients.JDDG;2008.6:98-104. [2] Cole PD,Stiles J,Boulad F,et al.Successful treatment of human herpesvirus 6 encephalitis in a bone marrow trans-plant recipient.Clin Infect Dis 1998 Sep; 27 (3): 653–4. [3] Slifkin M,Doron S,Snydman DR.Viral prophylaxis in organ transplant patients. Drugs 2004; 64 (24):2763–92. [4] Stockfleth E,Nindl I,Sterry W,et al.Human papil-lomaviruses in transplant-associated skin cancers.Dermatol Surg 2004 Apr;30 (4 Pt 2): 604–9. [5] Ulrich C,Christophers C,Sterry W,et al.Skin diseases in organ transplant recipients. Hautarzt 2002 Aug; 53 (8): 524–33. [6] Varon NF,Alangaden GJ.Emerging trends in infections among renal trans-plant recipients. Expert Rev Anti Infect Ther 2004 Feb; 2 (1): 95–109. [7] Marteli-marzagao F,Yamashiro AS,Ogawa MM,et al.Clinical and histopathological characterization and typing of the human papillomavirus in common warts of kidney transplant recipients.An Bras Dermatol.2010 Oct;85(5):743-6. [8] Roka S,Rasoul-Rockenschaub S,Roka J,Kirnbauer R,et al.Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004 Aug; 17 (7): 366–9. [9] Ahmadpoor P.Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation:mechanisms of tumor genesis.Iran J Kidney Dis.2009 Jul;3(3):121-6. [10]Bubic-Filipi Lj,Basic-Jukic N,Pasini J,et al.Clinical features of Kaposi’s sarcoma in Croatian renal transplant recipients.Prilozi.2009 Dec;30(2):175-84. [11] Gotti E,Remuzzi G.Post-transplant Kaposi’s sarcoma.J Am SocNephrol 1997; 8: 130–137. [12] Ryan J.Sullivan,Liron Pantanowitz,Bruce J.Dezube.Targeted therapy in Kaposi sarcoma.BioDrugs.2009;23(2):69-75. [13] Franco A,Jimenez L,Sillero C,et al.Post-transplant lymphoproliferative disorders in renal transplantation :two decades of experience.Nefrologia.2010 ;30(6) :669-75. [14] Choi JH,Park BB,Suh C,et al.Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.J Korean Med Sci.2010 Apr;25(4):523-6. [15] Borhani AA,Hosseinzadeh K,Almusa O,et al.Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation.Radiographics.2009 Jul-Aug;29(4):981-1000;discussion 1000-2. [16] Feng H,Shuda M,Chang Y,et al.Clonal integration of apolyomavirus in humanMerkel cell carcinoma. Science 2008; 319:1096–1100. [17] Athar M,Walsh SB,Kopelovich L,et al.Pathogenesis of nonmelanoma skin cancers in organ transplant recipients.Arch Biochem Biophys.2011 Apr 15;508(2):159-63. [18] I.Nindl,F.Rosl.Molecular Concepts of Virus Infections Causing Skin Cancer in Organ Transplant Recipients.American Journal of Transplantation 2008;8:2199-2204. [19] Purdie KJ, Surentheran T, Sterling JC Bell L,et al. Humanpapillomavirus gene expression in cuta-neous squamous cell carcinomas from immunosuppressed and immunocom-petent individuals. L Invest Dermatol 2005 Jul; 125 (1): 98–107. [20] Kalinova L,Majek O,Stehlik D,et al.Skin cancer incidence in renal transplant recipients-a single center study.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.2010 Sep;154(3):257-60. [21] Lane JE,Bowman PH,Cohen DJ.Epidermodysplasia verruciformis.South Med J 2003;96:613-615. [22] Jan N. Bouwes Bavinck, Sylvie Euvrard, Luigi Naldi,et al .Keratotic Skin Lesions and Other Risk Factors Are Associated with Skin Cancer in Organ-Transplant Recipients:A Case-Control Study in The Netherlands,United Kingdom,Germany,France,and Italy.J Invest Dermatol.2007 July;127(7):1647-1656. [23] Murphy G.Ultraviolet radiation and immunosuppression.Br J Dermatol.2009;161:90–5. [24] Beissert S,Schwarz T.Ultraviolet-induced immunosuppression:implications for photocarcinogenesis. Cancer Treat Res. 2009;146:109–21. [25] Amron D, Moy R.Stratospheric ozone depletion and its relationship to skin cancer. J Dermatol Surg Oncol.1991;17:370–2. [26] Emmert B,Hallier E,Schon MP,et al.Xeroderma pigmentosum(XP):A genetic disease sheds light on UV-induced skin cancer.Hautarzt.2011 Feb;62(2):91-7. [27] Queille S,Luron L,Spatz A,et al.Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.Carcinogenesis.2007 Mar;28(3):724-31. [28] Molina BD,Leiro MG,Pulpon LA,et al.Incidence and risk factors for nonmelanoma skin cancer after cancer after heart transplantation.Transplant Proc.2010 Oct;42(8):3001-5.